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Abstract Simultaneous treatment of serum-starved (24 h) Swiss 
3T3 cells with insulin (500 nM) and phosphocholine (PCho) 
(0.25-1 mM) resulted in synergistic stimulation of DNA 
synthesis via a mitogen activated protein (MAP) kinase-
independent rapamycin-sensitive mechanism. Co-treatment of 
cells with bombesin (10 nM) or zinc (25 μΙΥΙ) enhanced the 
combined mitogenic effects of insulin and PCho 2-3-fold; 
however, in the presence of bombesin or zinc the combined 
effects of insulin and PCho were not inhibited by rapamycin. The 
potentiating effects of bombesin and zinc on insulin plus PCho-
induced DNA synthesis were accompanied by large stimulation 
of p42 MAP kinase activity. The results indicate that in Swiss 
3T3 cell cultures, synergistic stimulation of DNA synthesis by 
extracellular insulin and PCho via a p42 MAP kinase-dependent 
mechanism requires the presence of other growth regulatory 
agents, such as bombesin or zinc. 
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1. Introduction 
Insulin alone is a weak mitogen in fibroblasts but it can 
complement the mitogenic signals initiated by competence 
factors such as platelet-derived growth factor, fibroblast 
growth factor, or epidermal growth factor [1]. Bombesin is 
another growth factor which can enhance the mitogenic activ-
ity of insulin in Swiss 3T3 fibroblasts [2,3]. It was reported 
that bombesin and insulin, in combination, stimulate entry of 
Swiss 3T3 cells into the S phase of the cell cycle by a mech-
anism which is independent of pp70 S6 kinase (pp70s6k) activ-
ity [4] and only partially depends on mitogen activated protein 
(MAP) kinase activity [5]. 
We have previously demonstrated that in NIH 3T3 fibro-
blasts phosphocholine (PCho), an intermediate of phosphati-
dylcholine synthesis, can also greatly enhance the relatively 
small stimulatory effect of insulin on DNA synthesis [6-8]. 
Since the intracellular concentration of PCho is relatively 
high, and there are mechanisms which can induce the release 
of cellular PCho to the extracellular space, PCho is likely to 
be a physiologically relevant regulator of cell growth in the 
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presence of insulin [8]. However, other growth regulatory 
agents, such as bombesin, could further modify the interde-
pendent mitogenic actions of PCho and insulin. The first goal 
in this work was to test this possibility. 
Zinc, present in the circulation at concentrations of 10-40 
μΜ, is known to be required for growth [9]. Therefore, it was 
important to determine how zinc might affect the mitogenic 
effects of insulin and PCho. This was the second impor-
tant goal of this work. We report that both bombesin and 
zinc further enhanced the initially MAP kinase-independent 
synergistic effects of insulin and PCho on DNA synthe-
sis by a mechanism which involved activation of p42 MAP 
kinase. 
2. Materials and methods 
2.1. Materials 
Insulin and bombesin were purchased from Boehringer Mannheim; 
PCho and rapamycin were bought from Sigma; the MAP kinase assay 
kit was obtained from New England Biolabs; tissue culture reagents 
were from Life Technologies, Inc.; and [rae¿/¡j/-3H]thymidine (85 Ci/ 
mmol) was purchased from NEN DuPont. 
2.2. Cell culture 
The Swiss 3T3 fibroblast line, bought from the American Type 
Culture Collection (Rockville, MD, USA), was continuously cultured 
in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) 
fetal calf serum, penicillin/streptomycin/neomycin (50 U/ml, 50 μg/ml 
and 100 μg/ml, respectively) and glutamine (2 mM). 
2.3. Labeling of cellular DNA with [3H]thymidine 
Swiss 3T3 cells were grown in 12-well tissue culture dishes to about 
40% confluency in the presence of 10% serum, washed, and then 
incubated in serum-free medium for 21 h. The medium was replaced 
with serum-free fresh medium and cells were incubated with or with-
out 25 μΜ zinc chloride for 3 h. This was followed by treatments for 
16 h in the absence or presence of PCho, bombesin and/or insulin; 
PCho was added to the incubation medium 5 min prior to bombesin, 
and bombesin was added to cells 5 min prior to insulin. Finally, 
incubations were continued in the presence of [mei/iy/-3H]thymidine 
(1 μΟΛνεΙΙ) for 60 min. The cells were washed twice with phosphate-
buffered saline, then four times with 5% trichloroacetic acid, and 
finally twice with absolute ethanol. The acid-insoluble material was 
redissolved in 0.3 M sodium hydroxide, and an aliquot was taken to 
measure DNA-associated 3H activity in a liquid scintillation counter. 
2.4. Determination of MAP kinase activity 
This was performed as described previously [8]. Briefly, serum-
starved untreated or zinc-treated (3 h) NIH 3T3 cells in 10 cm diam-
eter tissue culture dishes were first treated with 1 mM PCho for 5 min, 
then with 10 nM bombesin for 5 min, and finally with 500 nM insulin 
(in the continuous presence of PCho and bombesin, when applicable) 
for 10 min. The activity state of p42/p44 MAP kinases was evaluated 
by immunoblot analysis [8]. The phosphospecific MAP kinase anti-
body used here recognizes the tyrosine 204 phosphorylation site in the 
activated forms of MAP kinases. 
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Fig. 1. Concentration-dependent effects of PCho on DNA synthesis 
in the presence of insulin and bombesin in Swiss 3T3 cells. Serum-
starved cells were treated for 16 h with 0-1 mM concentrations of 
PCho, as indicated, in the absence (O) or presence of 10 nM bomb-
esin (·), 500 nM insulin ( Δ ) or bombesin plus insulin (A) . Each 
point represents the mean±S.E.M. of six determinations (from sep-
arate wells) in one experiment. Similar results were obtained in three 
other experiments each performed in triplicate. 
3. Results 
3.1. Synergistic effects of insulin, PCho, and bombesin on DNA 
synthesis 
Addition of bombesin to confluent serum-starved Swiss 3T3 
cells has been reported to cause significant stimulation of 
DNA synthesis [4,5]. In our hands, bombesin alone had mito-
genic effects only if the conditioned incubation medium had 
not been removed prior to the addition of bombesin. In con-
trast, when after a 21-24 h period of serum starvation the 
conditioned medium was replaced with fresh serum-free me-
dium shortly (0.5-3 h) before the addition of bombesin, this 
growth factor alone had no effect on DNA synthesis (Fig. 1). 
However, under these conditions bombesin clearly retained its 
ability to potentiate the small mitogenic effect of insulin (Fig. 
1). Since we were interested in the potentiating effect of bomb-
esin, we used this protocol throughout this study. In these 
cells 1 mM PCho alone enhanced DNA synthesis to about 
the same extent ( ~ 7-fold) as insulin did (Fig. 1). However, 
when added in combination, insulin and 1 mM PCho synerg-
istically ( ~ 30-fold) stimulated DNA synthesis (Fig. 1). Fur-
thermore, it should be noted that detectable potentiation of 
the insulin effect was also observed with 0.25 mM PCho (Fig. 
1). Bombesin approximately doubled the combined effects of 
insulin and PCho on DNA synthesis, while it did not modify 
the effect of PCho alone (Fig. 1). 
Rapamycin, an inhibitor of pp70s6k action [10,11], strongly 
inhibited the combined effects of bombesin and insulin on 
DNA synthesis, while the combined effects of insulin, bomb-
esin and PCho remained practically unaffected by rapamycin 
Fig. 2. Effects of rapamycin and wortmannin on DNA synthesis in-
duced by combinations of bombesin, PCho, and insulin. Serum-
starved Swiss 3T3 cells were incubated for 16 h in the absence 
(white bars) or presence of 10 nM bombesin (hatched bars), bombe-
sin plus 500 nM insulin (cross-hatched bars) or bombesin plus insu-
lin plus 1 mM PCho (black bars). There was either no other addi-
tion (I), or the incubation medium also contained 10 nM rapamycin 
(II) or 200 nM wortmannin (III) added 30 min prior to other addi-
tions. Values are the means ± S.E.M. of four determinations (from 
separate wells) in one experiment. Similar results were obtained in 
two other experiments each performed in triplicate. 
(Fig. 2). On the other hand, even a relatively high (200 nM) 
concentration of wortmannin, an inhibitor of phosphatidyl-
inositol 3'-kinase [12,13], failed to inhibit the synergistic mito-
genic effects of insulin and bombesin both in the absence and 
presence of PCho (Fig. 2). 
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Fig. 3. Potentiating effect of zinc on PCho plus insulin-induced 
DNA synthesis. Serum-starved Swiss 3T3 cells were treated for 16 h 
with 0-1 mM concentrations of PCho, as indicated, in the absence 
(O) or presence of 25 μΜ zinc (·), 500 nM insulin ( Δ ) , or zinc 
plus insulin ( A ) ; zinc was added 3 h prior to other additions. Each 
point represents the mean + S.E.M. of six determinations (from sep-
arate wells) in one experiment. Similar results were obtained in five 
other experiments performed in triplicate or duplicate. 
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3.2. Combined effects of insulin, PCho, and zinc on DNA 
synthesis 
Zinc, present in the circulation at concentrations of 1(MK) 
μΜ, is an essential micronutrient which is required for normal 
cell growth [9]. We tested its effects on insulin and PCho-
induced DNA synthesis at a physiologically relevant concen-
tration (25 μΜ). While zinc did not significantly modify the 
individual effects of PCho or insulin on DNA synthesis, it 
nearly doubled the combined effects of insulin and PCho at 
each (0.25-1 mM) concentration of PCho examined (Fig. 3). 
In the absence of zinc, a maximally effective (10 nM) con-
centration of rapamycin inhibited the stimulatory effects of 
insulin, PCho, and insulin plus PCho by about 80%, 45%, 
and 63%, respectively (Fig. 4A). In the presence of zinc, ra-
pamycin inhibited the individual effects of insulin and PCho 
to about the same extent as it did in the absence of zinc; 
however, in the presence of zinc the synergistic effects of in-
sulin and PCho were inhibited by rapamycin only by about 
25% (Fig. 4B). 
3.3. Activation of MAP kinase by PCho plus insulin in the 
presence of bombesin or zinc 
The results described so far implied that both bombesin and 
zinc decreased the dependence of combined mitogenic effects 
PCho and insulin on pp70s6k. This prompted us to examine 
activation of MAP kinase by PCho and insulin in the presence 
of bombesin and zinc. As shown in Fig. 5, PCho and insulin, 
even in combination, only slightly enhanced p42 MAP kinase 
activity. Similarly, insulin and bombesin in combination had 
only a small stimulatory effect on this MAP kinase activity 
(Fig. 5). However, p42 MAP kinase activity was greatly in-
creased when treatments with PCho plus insulin were per-
formed in the presence of either bombesin or zinc (Fig. 5). 
In similar studies, zinc failed to enhance the combined effects 
of PCho, bombesin, and insulin on either DNA synthesis or 
p42 MAP kinase activity (data not shown). It should be added 
that while in an earlier work insulin in combination with 
Fig. 4. Effects of rapamycin on DNA synthesis induced by combi-
nations of zinc, PCho and insulin. Serum-starved Swiss 3T3 cells 
were incubated for 16 h without zinc (A) or with 25 μΜ zinc (B) in 
the absence (white bars) or presence of 500 nM insulin (hatched 
bars), 1 mM PCho (cross-hatched bars) or insulin plus PCho (black 
bars). Rapamycin (10 nM), either absent (I) or present (II) during 
the entire treatment period (16 h) was added 30 min prior to other 
additions. Values represent the means ± S.E.M. of four determina-
tions (from separate wells) in one experiment. Similar results were 
obtained in two other experiments each performed in triplicate. 
Fig. 5. Potentiating effects of bombesin and zinc on PCho plus insu-
lin-induced MAP kinase activity. Serum-starved Swiss 3T3 cells 
were either untreated (lane 2), or were treated for a total period of 
20 min (except with zinc) with 1 mM PCho plus 500 nM insulin 
(lane 3), PCho plus insulin plus 25 μΜ zinc (added 3 h prior to 
other additions) (lane 4), insulin plus 10 nM bombesin (lane 5), and 
PCho plus insulin plus bombesin (lane 6). The MAP kinase stand-
ard is shown in lane 1. This experiment was repeated once with sim-
ilar results. 
phorbol ester was found to stimulate both p42 and p44 
MAP kinase activities [8], in the present study combinations 
of insulin with PCho and bombesin or zinc did not cause 
detectable activation of p44 MAP kinase (Fig. 5). 
4. Discussion 
Bombesin has been reported to stimulate DNA synthesis 
through several signal transduction pathways. When added 
to confluent and serum-starved cells without prior change of 
the conditioned medium, bombesin alone was found to stim-
ulate DNA synthesis by both pp70s6k-dependent [11] and 
MAP kinase-dependent mechanisms [14]. Interestingly, under 
the above incubation condition synergistic activation of DNA 
synthesis by bombesin and insulin showed reduced require-
ment for both the pp70s6k-dependent [4] and MAP kinase-
dependent [5] signal transduction pathways. Thus, in the pres-
ence of insulin, bombesin can also stimulate DNA synthesis 
by a third, presently unidentified, mechanism. 
We significantly decreased the complexity of bombesin ac-
tion by including a washing step shortly before its addition. 
This step eliminated the effect of bombesin 'alone' (requiring a 
factor present in the conditioned medium), but preserved its 
potentiating effect on insulin-induced DNA synthesis. Impor-
tantly, while the combined effects of bombesin and insulin as 
well as that of PCho and insulin on DNA synthesis were 
strongly inhibited by rapamycin, the combined effects of 
PCho, bombesin and insulin were much less sensitive to the 
inhibitory action of rapamycin. The three agents together also 
induced a much greater activation of p42 MAP kinase than 
that elicited by insulin in combination with either bombesin or 
PCho. Collectively, these data imply that bombesin is capable 
of shifting the combined mitogenic effects of PCho and insulin 
from a rapamycin-sensitive (presumably pp70s6k-dependent) 
to a p42 MAP kinase-dependent pathway which is insensitive 
to rapamycin. 
In the periphery, the serum concentration of zinc appears to 
be in the 10-20 μΜ range [9] which can be doubled under 
certain conditions including stress [15]. In view of the multiple 
roles of zinc in cell growth regulation [9], it was interesting to 
find that zinc not only permitted but actually further pro-
moted the mitogenic effects of PCho and insulin on DNA 
synthesis. Furthermore, zinc was also able to divert the com-
bined effects of PCho and insulin from a rapamycin-sensitive 
to a MAP kinase-dependent mechanism. This suggests that 
74 Z. Kiss et allFEBS Letters 415 (1997) 71-74 
the level of zinc in the circulation may have a significant 
impact on mitogenesis induced by extracellular PCho and in-
sulin. 
In summary, we have shown that in Swiss 3T3 cells the 
combined stimulatory effects of PCho and insulin on D N A 
synthesis are enhanced by both bombesin and zinc. The mech-
anisms by which bombesin and zinc are able to switch the 
mitogenic actions of PCho and insulin from a rapamycin-sen-
sitive to a rapamycin-insensitive M A P kinase-dependent 
mechanism remain to be established. 
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